Peregrine Capital Management LLC Illumina, Inc. Transaction History

Peregrine Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 20, 2020	SELL	$268.51 - $400.74 $24.6 Million - $36.8 Million	-91,781 Closed	0 $0
Q2 2020 Jul 30, 2020	BUY	$256.46 - $373.01 $749,632 - $1.09 Million	2,923 Added 3.29%	91,781 $34 Million
Q1 2020 Apr 17, 2020	BUY	$209.2 - $335.53 $143,929 - $230,844	688 Added 0.78%	88,858 $24.3 Million
Q4 2019 Jan 16, 2020	BUY	$288.29 - $335.49 $98,306 - $114,402	341 Added 0.39%	88,170 $29.2 Million
Q3 2019 Oct 16, 2019	BUY	$266.84 - $378.23 $2.71 Million - $3.84 Million	10,155 Added 13.07%	87,829 $26.7 Million
Q1 2019 Apr 12, 2019	BUY	$272.57 - $321.18 $251,854 - $296,770	924 Added 1.2%	77,674 $0
Q4 2018 Jan 17, 2019	BUY	$272.46 - $366.54 $520,943 - $700,824	1,912 Added 2.55%	76,750 $23 Million
Q3 2018 Oct 18, 2018	SELL	$279.04 - $367.06 $558 - $734	-2 Reduced -0.0%	74,838 $0
Q2 2018 Jul 12, 2018	BUY	$228.17 - $292.07 $5.41 Million - $6.93 Million	23,715 Added 46.39%	74,840 $0
Q1 2018 Apr 16, 2018	BUY	$209.54 - $253.91 $10.7 Million - $13 Million	51,125 New	51,125 $0

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.